Acute Pain Study Following Bunionectomy
Completed · Phase 2 · Has a placebo group
Conditions studied: Pain
In brief
The primary purpose of this study was to evaluate analgesic efficacy and safety of hydrocodone/acetaminophen extended release compared to placebo in the treatment of moderate to severe pain following bunionectomy.
Key facts
- Study ID
- NCT01333722
- Run by
- AbbVie (prior sponsor, Abbott)
- People needed
- 100
- Starts
- 2011-04-01
- Expected to finish
- 2011-06-01
- Last updated by the study team
- 2014-04-08
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subjects who were in general good health, experiencing moderate to severe pain following bunionectomy
You may not qualify if…
- Subjects who underwent Base wedge osteotomy and / or Long-Z Hart bunionectomy procedures
- Drug allergies to hydrocodone, acetaminophen
- Clinically significant or uncontrolled medical disorders or illness - history of drug or alcohol abuse / addiction
Where it is running
- Site Reference ID/Investigator# 51464 — Pasadena, California, United States
- Site Reference ID/Investigator# 51602 — Austin, Texas, United States
- Site Reference ID/Investigator# 51344 — Salt Lake City, Utah, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.